Rock Creek Group, LP Edwards Lifesciences Corp Transaction History

Rock Creek Group, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $11,168 - $13,721	-105 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $10,805 - $12,888	105 New	105 $12,000
Q2 2020 Aug 13, 2020	SELL	$57.54 - $76.95 $230,217 - $307,876	-4,001 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $209,692 - $324,081	4,001 New	4,001 $755,000

1,418

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.